124 related articles for article (PubMed ID: 2877865)
1. Evidence that growth hormone-releasing factor stimulates somatostatin release in vitro via beta-endorphin.
Aguila MC; McCann SM
Endocrinology; 1987 Jan; 120(1):341-4. PubMed ID: 2877865
[TBL] [Abstract][Full Text] [Related]
2. The effect of galanin on growth hormone-releasing factor and somatostatin release from median eminence fragments in vitro.
Aguila MC; Marubayashi U; McCann SM
Neuroendocrinology; 1992 Dec; 56(6):889-94. PubMed ID: 1285434
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of somatostatin release in vitro by synthetic human growth hormone-releasing factor by a nondopaminergic mechanism.
Aguila MC; McCann SM
Endocrinology; 1985 Aug; 117(2):762-5. PubMed ID: 2862013
[TBL] [Abstract][Full Text] [Related]
4. Calmodulin dependence of somatostatin release stimulated by growth hormone-releasing factor.
Aguila MC; McCann SM
Endocrinology; 1988 Jul; 123(1):305-9. PubMed ID: 2898360
[TBL] [Abstract][Full Text] [Related]
5. Role of arachidonic acid or its metabolites in growth-hormone-releasing factor-induced release of somatostatin from the median eminence.
Aguila MC; Milenkovic L; McCann SM; Snyder GD
Neuroendocrinology; 1990 Sep; 52(3):238-42. PubMed ID: 1977095
[TBL] [Abstract][Full Text] [Related]
6. Alpha-melanocyte stimulating hormone discloses a stimulatory effect of beta-endorphin on somatostatin release.
Aguila MC; Khorram O; McCann SM
Brain Res; 1987 Aug; 417(1):127-30. PubMed ID: 2887255
[TBL] [Abstract][Full Text] [Related]
7. The inhibition of growth hormone release by gastrin-releasing peptide involves somatostatin release.
Kentroti S; Aguila MC; McCann SM
Endocrinology; 1988 Jun; 122(6):2407-11. PubMed ID: 2897283
[TBL] [Abstract][Full Text] [Related]
8. Effect of fetal ethanol exposure on the in vitro release of growth hormone, somatostatin and growth hormone-releasing factor induced by clonidine and growth hormone feedback in male and female rats.
Conway S; Ling SY; Leidy JW; Blaine K; Holtzman T
Alcohol Clin Exp Res; 1997 Aug; 21(5):826-39. PubMed ID: 9267532
[TBL] [Abstract][Full Text] [Related]
9. Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men.
Devesa J; Diaz MJ; Tresguerres JA; Arce V; Lima L
J Clin Endocrinol Metab; 1991 Aug; 73(2):251-6. PubMed ID: 1677361
[TBL] [Abstract][Full Text] [Related]
10. Paradoxical enhancement of pituitary growth hormone (GH) responsiveness to GH-releasing factor in the face of high somatostatin tone.
Tannenbaum GS; Painson JC; Lengyel AM; Brazeau P
Endocrinology; 1989 Mar; 124(3):1380-8. PubMed ID: 2563683
[TBL] [Abstract][Full Text] [Related]
11. Effects of rat growth hormone (rGH)-releasing factor and somatostatin on the release and synthesis of rGH in dispersed pituitary cells.
Fukata J; Diamond DJ; Martin JB
Endocrinology; 1985 Aug; 117(2):457-67. PubMed ID: 2862007
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of platelet-activating factor (PAF) on luteinizing hormone-releasing hormone and somatostatin release from rat median eminence in vitro correlated with the characterization of specific PAF receptor sites in rat hypothalamus.
Junier MP; Tiberghien C; Rougeot C; Fafeur V; Dray F
Endocrinology; 1988 Jul; 123(1):72-80. PubMed ID: 2898362
[TBL] [Abstract][Full Text] [Related]
13. Combined effects of human growth hormone (GH)-releasing factor-44 (GRF) and somatostatin (SRIF) on post-SRIF rebound release of GH and prolactin: a model for GRF-SRIF modulation of secretion.
Stachura ME; Tyler JM; Farmer PK
Endocrinology; 1988 Sep; 123(3):1476-82. PubMed ID: 2900135
[TBL] [Abstract][Full Text] [Related]
14. Physiologically significant effect of neuropeptide Y to suppress growth hormone release by stimulating somatostatin discharge.
Rettori V; Milenkovic L; Aguila MC; McCann SM
Endocrinology; 1990 May; 126(5):2296-301. PubMed ID: 1970290
[TBL] [Abstract][Full Text] [Related]
15. Somatostatin-stimulated growth hormone-releasing factor secretion in vitro is modified by fetal ethanol exposure.
Conway S; Swain R
Alcohol Clin Exp Res; 1997 Jun; 21(4):703-9. PubMed ID: 9194927
[TBL] [Abstract][Full Text] [Related]
16. Altered pituitary growth hormone (GH) regulation in streptozotocin-diabetic rats: a combined defect of hypothalamic somatostatin and GH-releasing factor.
Olchovsky D; Bruno JF; Wood TL; Gelato MC; Leidy JW; Gilbert JM; Berelowitz M
Endocrinology; 1990 Jan; 126(1):53-61. PubMed ID: 1967164
[TBL] [Abstract][Full Text] [Related]
17. Effect of withdrawal of somatostatin and growth hormone (GH)-releasing factor on GH release in vitro.
Kraicer J; Sheppard MS; Luke J; Lussier B; Moor BC; Cowan JS
Endocrinology; 1988 May; 122(5):1810-5. PubMed ID: 2896117
[TBL] [Abstract][Full Text] [Related]
18. Effect of somatostatin withdrawal and growth hormone (GH)-releasing factor on GH release in vitro: amount available for release after disinhibition.
Kraicer J; Cowan JS; Sheppard MS; Lussier B; Moor BC
Endocrinology; 1986 Nov; 119(5):2047-51. PubMed ID: 2876882
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor I modulates hypothalamic somatostatin through a growth hormone releasing factor increased somatostatin release and messenger ribonucleic acid levels.
Aguila MC; Boggaram V; McCann SM
Brain Res; 1993 Oct; 625(2):213-8. PubMed ID: 7903898
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of hypothalamic medial preoptic area somatostatin on growth hormone-releasing factor in the rat.
Katakami H; Downs TR; Frohman LA
Endocrinology; 1988 Aug; 123(2):1103-9. PubMed ID: 2899498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
